Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes

Table 7 Correlations of interleukin-1β, adiponectinresistin with clinical and laboratory variables in subjects with diabetic foot

Variable	Adipenectin		Resistin		IL-6
	R	P values	R	P values
Diabetes duration	0.36 (s)	< 0.001 (s)	0.09	0.37
Smoking	0.35 (s)	< 0.001 (s)	0.10	0.22
Hypertension	0.27 (s)	< 0.05 (s)	0.12	0.35
Dyslipidaemia	0.42 (s)	< 0.001 (s)	0.14	0.15
Obesity	0.13	0.42	0.12	0.22
Chronicrenalfailure	0.11	0.56	0.12	0.35
Mycroalbuminuria	0.08	0.37	0.08	0.37
Retinopathty	0.10	0. 7	0.10	0. 7
AOPC	0.11	0.81	0.10	0.77
CHD	0.46	< 0.001 (s)	0.38 (s)	< 0.0001 (s)
TIA/stroke	0.12	0.42	0.13	0.32
Other district atherosclerosis	0.15 (s)	0.42 (s)	0.14 (s)	0.36 (s)

Coefficients (R) and P values are calculated by the Pearson correlation mode. Modified from Tuttolomondo et al[21]. s: Significative; CRP: C-reactive protein; TNF-α: Tumor necrosis factor-α; IL-1β: Interleukin-1β; IL-6: Interleukin-6; IL-10: Interleukin-10; ICAM-1: Intercellular adhesion molecule-1; V-CAM-1: Vascular cell adhesion molecule-1; vWF: Von willebrand factor; TPA: Tissue plasminogen activator; PAI-1: Plasminogen activator inhibitor-1.